Virus-like particles (VLPs) can be spontaneously self-assembled by viral structural proteins
under appropriate conditions in vitro while excluding the genetic material and potential …

Virus-like particles (VLPs) have been produced as candidate vaccines in plants virtually
since the introduction of biofarming. Even today, VLPs remain the best candidates for safe …

Virus-like particles (VLPs) are known as self-assembled, non-replicative and non-infectious
protein particles, which imitate the formation and structure of original wild type viruses …

After its emergence in late 2019 SARS-CoV-2 was declared a pandemic by the World Health
Organization on 11 March 2020 and has claimed more than 2.8 million lives. There has …

New nanocarrier technologies are emerging, and they have great potential for improving
drug delivery, targeting efficiency and bioavailability. Virus-like particles (VLPs) are natural …

Abstract Background Virus-like particles (VLPs) are supramolecular structures composed of
multiple protein subunits and resemble natural virus particles in structure and size, making …

Multifunctional nanocarriers harbouring specific targeting moieties and with pH-responsive
properties offer great potential for targeted cancer therapy. Several synthetic drug carriers …

Multifunctional nanocarriers displaying specific ligands and simultaneously response to
stimuli offer great potentials for targeted and controlled drug delivery. Several synthetic …

Skin cancer or cutaneous carcinoma, is a pre-eminent global public health problem with no
signs of plateauing in its incidence. As the most common treatments for skin cancer, surgical …

Lack of targeting and improper biodistribution are major flaws in current drug-based
therapies that prevent reaching high local concentrations of the therapeutic agent. Such …